Remarkable effect of a phosphodiesterase type 3 inhibitor, milrinone in a reversible cerebral vasoconstriction syndrome patient with ischemic stroke: A case report
Naoki Oyama(Kawasaki Medical School), Hideki Mochizuki(Osaka Gakuin University), Sho Murase(The University of Osaka), Kenichi Todo(Osaka City University), Yasufumi Gon(Osaka City University), Akihiro Watanabe(Niigata Cancer Center Hospital), Shunsuke Saito(The University of Osaka), Junji Yamamoto(National Defense Medical College), Tsutomu Sasaki(The University of Osaka), Manabu Sakaguchi(Osaka Prefectural Medical Center), Kyoko Higashida(Osaka Prefectural Medical Center), Y. Terasaki, Yoshiki Sawa(Osaka Police Hospital), K. Toda(The University of Osaka)
Cited by 1
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
|Molecular Brain|2012|392
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
One Hundred Two Consecutive Hepatobiliary Resections for Perihilar Cholangiocarcinoma With Zero Mortality
|Annals of Surgery|2006|216